| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner
1 company
Anderson Edward T is a Director, 10% Owner at Lyra Therapeutics, Inc.. Recent SEC Form 4 filings include 10 buys and 3 sells.
Estimated insider holdings value: $1.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 31, 2023 | LYRA Lyra Therapeutics, Inc. | Director, 10% Owner | Buy | 1,805,416 | $2.43 | $4,387,160.88 | +44.2% | +32.7% | -87.1% | |
| Apr 12, 2022 | LYRA Lyra Therapeutics, Inc. | Director, 10% Owner | Buy | 2,488,150 | $4.22 | $10,499,993.00 | +145.2% | -1.8% | -59.5% | |
| May 5, 2020 | LYRA Lyra Therapeutics, Inc. | Director, 10% Owner | Sell | 24,183 | $16.00 | $386,928.00 | -1.6% | - | - | |
| May 5, 2020 | LYRA Lyra Therapeutics, Inc. | Director, 10% Owner | Buy | 250,000 | $16.00 | $4,000,000.00 | +17.1% | - | - |